Patents by Inventor Hetem Soliman

Hetem Soliman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION INCLUDING A CPG-C TYPE OLIGONUCLEOTIDE AND A PD-1 ANTAGONIST FOR TREATING BREAST CANCER
    Publication number: 20210315991
    Abstract: The present disclosure describes combination therapies for breast cancer comprising an oligonucleotide toll-like receptor 9 agonist and a PD-1 antagonist. In particular, the present disclosure describes combinations of a CpG-C type oligonucleotide and an anti-PD-1 antibody for the treatment of breast cancer. The combination may further comprise a taxane chemotherapeutic agent, in the presence or absence of a corticosteroid.
    Type: Application
    Filed: April 13, 2021
    Publication date: October 14, 2021
    Applicants: Surefire Medical, Inc. d/b/a TriSalus Life Sciences, The Regents of the University of California, H. Lee Moffitt Cancer Center and Research Institute, Inc.
    Inventors: Robert S. Janssen, Erick Gamelin, Laura J. Esserman, Amy Jo Chien, Hetem Soliman